冠心病患者PCI术后应用替罗非班临床疗效与安全性研究
发布时间：2018-07-16 08:44
【摘要】：冠心病发病率逐年升高,PCI术后应用替罗非班可以减少患者缺血事件,降低患者死亡率,然而出血、血小板减少等并发症是不可忽视的,关于如何合理应用替罗非班使其发挥最大作用又减少并发症,我们进行了研究。
[Abstract]:The incidence of coronary heart disease is increasing year by year. The use of tirofiban after PCI can reduce the ischemic events and reduce the mortality of patients. However, complications such as hemorrhage and thrombocytopenia can not be ignored. We have studied how to use tirofiban properly to maximize its effectiveness and reduce complications.
【作者单位】： 济南大学;山东省医学科学院医学与生命科学学院;山东省医学科学院附属济宁市第一人民医院心内科;济宁市第一人民医院高新区分院心内科;
【分类号】：R541.4
[Abstract]:The incidence of coronary heart disease is increasing year by year. The use of tirofiban after PCI can reduce the ischemic events and reduce the mortality of patients. However, complications such as hemorrhage and thrombocytopenia can not be ignored. We have studied how to use tirofiban properly to maximize its effectiveness and reduce complications.
【作者单位】： 济南大学;山东省医学科学院医学与生命科学学院;山东省医学科学院附属济宁市第一人民医院心内科;济宁市第一人民医院高新区分院心内科;
【分类号】：R541.4
【相似文献】
相关期刊论文 前10条
1 申红远;梁伟;汤U，
本文编号：2125869
本文链接：https://www.wllwen.com/yixuelunwen/xxg/2125869.html
最近更新
教材专著
